Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
AJNR Am J Neuroradiol ; 36(1): 108-15, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25355814

ABSTRACT

BACKGROUND AND PURPOSE: Flow diverters are increasingly used in the endovascular treatment of intracranial aneurysms. Our aim was to determine neurologic complication rates following Pipeline Embolization Device placement for intracranial aneurysm treatment in a real-world setting. MATERIALS AND METHODS: We retrospectively evaluated all patients with intracranial aneurysms treated with the Pipeline Embolization Device between July 2008 and February 2013 in 17 centers worldwide. We defined 4 subgroups: internal carotid artery aneurysms of ≥10 mm, ICA aneurysms of <10 mm, other anterior circulation aneurysms, and posterior circulation aneurysms. Neurologic complications included spontaneous rupture, intracranial hemorrhage, ischemic stroke, permanent cranial neuropathy, and mortality. Comparisons were made with t tests or ANOVAs for continuous variables and the Pearson χ(2) or Fisher exact test for categoric variables. RESULTS: In total, 793 patients with 906 aneurysms were included. The neurologic morbidity and mortality rate was 8.4% (67/793), highest in the posterior circulation group (16.4%, 9/55) and lowest in the ICA <10-mm group (4.8%, 14/294) (P = .01). The spontaneous rupture rate was 0.6% (5/793). The intracranial hemorrhage rate was 2.4% (19/793). Ischemic stroke rates were 4.7% (37/793), highest in patients with posterior circulation aneurysms (7.3%, 4/55) and lowest in the ICA <10-mm group (2.7%, 8/294) (P = .16). Neurologic mortality was 3.8% (30/793), highest in the posterior circulation group (10.9%, 6/55) and lowest in the anterior circulation ICA <10-mm group (1.4%, 4/294) (P < .01). CONCLUSIONS: Aneurysm treatment with the Pipeline Embolization Device is associated with the lowest complication rates when used to treat small ICA aneurysms. Procedure-related morbidity and mortality are higher in the treatment of posterior circulation and giant aneurysms.


Subject(s)
Embolization, Therapeutic/instrumentation , Endovascular Procedures/instrumentation , Intracranial Aneurysm/therapy , Aged , Aged, 80 and over , Embolization, Therapeutic/adverse effects , Endovascular Procedures/adverse effects , Female , Humans , Male , Middle Aged , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies
2.
J Biol Chem ; 276(29): 27214-20, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11454875

ABSTRACT

A signaling cascade that includes protein kinase C (PKC), Ras, and MEKK1 regulates involucrin (hINV) gene expression in epidermal keratinocytes (Efimova, T., LaCelle, P., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395 and Efimova, T., and Eckert, R. L. (2000) J. Biol. Chem. 275, 1601-1607). Because signal transfer downstream of MEKK1 may involve several MAPK kinases (MEKs), it is important to evaluate the regulatory role of each MEK isoform. In the present study we evaluate the role of MEK6 in transmitting this signal. Constitutively active MEK6 (caMEK6) increases hINV promoter activity and increases endogenous hINV levels. The caMEK6-dependent increase in gene expression is inhibited by the p38 MAPK inhibitor, SB203580, and is associated with a marked increase in p38alpha MAPK activity; JNK and ERK kinases are not activated. In addition, hINV gene expression is inhibited by dominant-negative p38alpha and increased when caMEK6 and p38alpha are co-expressed. caMEK6 also activates p38delta, but p38delta inhibits the caMEK6-dependent activation. These results suggest that MEK6 increases hINV gene expression by regulating the balance between activation of p38alpha, which increases gene expression, and p38delta, which decreases gene expression.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/physiology , Gene Expression Regulation, Enzymologic/physiology , Mitogen-Activated Protein Kinases/metabolism , Protein Precursors/genetics , Base Sequence , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Cells, Cultured , DNA Primers , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/pharmacology , MAP Kinase Kinase 6 , Promoter Regions, Genetic , Pyridines/pharmacology , p38 Mitogen-Activated Protein Kinases
3.
J Biol Chem ; 276(11): 8059-63, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11244091

ABSTRACT

Previous studies suggest that a PKC/Ras/MEKK1 cascade regulates involucrin (hINV) gene expression in human epidermal keratinocytes. MEK7, which is expressed in epidermis, has been identified as a member of this cascade (Efimova, T., LaCelle, P., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395 and Efimova, T., and Eckert, R. L. (2000) J. Biol. Chem. 275, 1601-1607). However, the kinase that functions downstream of MEK7 has not been identified. Our present studies show that MEK7 expression in keratinocytes markedly activates p38alpha and modestly activates JNK. Activation of p38 MAPK by MEK7 is a novel finding, as previous reports have assigned MEK7 as a JNK regulator. We also demonstrate that this regulation is physiologically important, as the p38alpha- and JNK-dependent activities regulate hINV promoter activity and expression of the endogenous hINV gene.


Subject(s)
Keratinocytes/enzymology , Mitogen-Activated Protein Kinase Kinases/physiology , Mitogen-Activated Protein Kinases/metabolism , Cells, Cultured , Enzyme Activation , Humans , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 7 , Mitogen-Activated Protein Kinases/physiology , Promoter Regions, Genetic , Protein Precursors/genetics , p38 Mitogen-Activated Protein Kinases
4.
Biophys J ; 79(6): 3052-62, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106611

ABSTRACT

We have examined permeation by Ca(2+) and Ba(2+), and block by Mg(2+), using whole-cell recordings from alpha1G T-type calcium channels stably expressed in HEK 293 cells. Without Mg(o)(2+), inward currents were comparable with Ca(2+) and Ba(2+). Surprisingly, three other results indicate that alpha1G is actually selective for Ca(2+) over Ba(2+). 1) Mg(2+) block is approximately 7-fold more potent with Ba(2+) than with Ca(2+). With near-physiological (1 mM) Mg(o)(2+), inward currents were approximately 3-fold larger with 2 mM Ca(2+) than with 2 mM Ba(2+). The stronger competition between Ca(2+) and Mg(2+) implies that Ca(2+) binds more tightly than Ba(2+). 2) Outward currents (carried by Na(+)) are blocked more strongly by Ca(2+) than by Ba(2+). 3) The reversal potential is more positive with Ca(2+) than with Ba(2+), thus P(Ca) > P(Ba). We conclude that alpha1G can distinguish Ca(2+) from Ba(2+), despite the similar inward currents in the absence of Mg(o)(2+). Our results can be explained by a 2-site, 3-barrier model if Ca(2+) enters the pore 2-fold more easily than Ba(2+) but exits the pore at a 2-fold lower rate.


Subject(s)
Barium/pharmacology , Calcium Channels, T-Type/physiology , Calcium/pharmacology , Magnesium/pharmacology , Animals , Calcium Channels, T-Type/chemistry , Calcium Channels, T-Type/drug effects , Cations, Divalent/pharmacology , Cell Line , Humans , Kinetics , Membrane Potentials/drug effects , Membrane Potentials/physiology , Rats , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Transfection
5.
Int J Oncol ; 17(6): 1195-203, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11078805

ABSTRACT

TIG3 is a recently discovered class II tumor suppressor protein, originally isolated from retinoid-treated cultured epidermal keratinocytes, that suppresses the proliferation of a variety of epithelial cell types. In the present study, we examine the ability of this protein to reduce CHO, T47D and HaCaT cell proliferation, and the role of the carboxy-terminal hydrophobic domain in this regulation. Vector-mediated expression of the full length TIG3 protein, TIG31-164, results in a 50-70% reduction colony formation efficiency. Expression of a truncated mutant, TIG31-134, that lacks the putative carboxy-terminal membrane-anchoring domain, results in a partial loss of ability to suppress colony formation. The fact that the truncated protein remains partially active suggests that both the amino- and carboxy-terminal regions of TIG3 are required for optimal growth suppression. The full-length protein is distributed in a perinuclear location, and is not present in the nucleus. TIG31-134, in contrast, is distributed in the cytoplasm. Thus, a change in location is associated with the partial loss of activity. We also monitored the distribution of green fluorescent protein (GFP)-TIG3 fusion proteins. GFP-TIG31-164 was localized in a pattern similar to that observed for TIG31-164, while GFP-TIG31-134 displayed a distribution pattern similar to GFP. This suggests that the c-terminal hydrophobic domain has an important role in determining the intracellular localization of TIG3. In addition, GFP-TIG31-164 retains the ability to inhibit cell function, while GFP-TIG31-134 is inactive.


Subject(s)
Carrier Proteins/chemistry , Receptors, Retinoic Acid , Amino Acid Sequence , Animals , CHO Cells , Carrier Proteins/genetics , Carrier Proteins/physiology , Cell Division , Cell Line , Cricetinae , Cricetulus , DNA, Complementary/genetics , Genes, Tumor Suppressor , Mice , Microscopy, Confocal , Molecular Sequence Data , Peptide Fragments/genetics , Peptide Fragments/physiology , Protein Conformation , Protein Structure, Tertiary , Protein Transport , Rats , Recombinant Fusion Proteins/physiology , Sequence Alignment , Sequence Homology, Amino Acid , Structure-Activity Relationship , Subcellular Fractions , Transfection , Tumor Cells, Cultured , Tumor Stem Cell Assay
6.
Neurosurgery ; 45(1): 175-8, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10414583

ABSTRACT

OBJECTIVE AND IMPORTANCE: Melanotic neuroectodermal tumor of infancy (MNTI) is a rare, locally aggressive tumor that arises most commonly from the maxilla or mandible. Infrequently, it originates from the cranial vault, and recent reports have described a favorable outcome after radical surgery. Some lesions are particularly problematic, such as those located along the cranial midline or cranial base and those with significant intracranial extension. Currently, there is no effective adjuvant therapy for MNTI; radiation is precluded by the patients' young age, and chemotherapy trials have not demonstrated long-term efficacy. CLINICAL PRESENTATION: A 2-month-old infant boy presented with a firm, immobile subcutaneous mass behind the right ear. The mass had been present at birth and enlarged with time. INTERVENTION: Initial resective surgery down to the dura resulted in massive tumor recurrence within weeks. Successful management required repeat surgery including excision of the dura and dural venous sinuses. CONCLUSION: This patient's large MNTI of the cranial base was successfully managed by radical surgery. Although MNTI is a rapidly growing tumor that is locally highly invasive, radical surgery may be associated with a favorable outcome and offers the potential for long-term cure.


Subject(s)
Neuroectodermal Tumor, Melanotic/congenital , Skull Base Neoplasms/congenital , Humans , Infant , Male , Neoplasm Invasiveness , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Neuroectodermal Tumor, Melanotic/pathology , Neuroectodermal Tumor, Melanotic/surgery , Prognosis , Reoperation , Skull Base/pathology , Skull Base/surgery , Skull Base Neoplasms/pathology , Skull Base Neoplasms/surgery
7.
Pediatr Neurosurg ; 31(6): 302-6, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10702730

ABSTRACT

The purpose of this study was to examine the current patterns of head trauma associated with child abuse. We reviewed the records of all patients admitted to our medical center between 1995 and 1997 with a primary diagnosis of head trauma, and analyzed the clinical presentation, mechanism of injury, socioeconomic status and outcome for these patients. Head trauma was deliberately inflicted in 38/405 children (9%). There were 25 boys and 13 girls, with a median age of 5.5 months. Two thirds of the families lived in the inner city. Of the 99 children under the age of 2 years admitted for head trauma, the injury was inflicted in 32 (32%). Acute subdural hematoma was present in 22/32 (69%) of children with inflicted trauma, but in only 5/68 (7%) with accidental trauma. Retinal hemorrhages were present in 17/32 (53%) abused children, but in no cases of accidental trauma (0/68). Deliberately inflicted injury is a frequent cause of serious head trauma in young children. Head injury is a major cause of morbidity and mortality in the abused child. Child abuse cases correlated strongly with low socioeconomic status. Nonaccidental trauma must be considered strongly in children under 2 years of age who present with acute subdural hematoma in the absence of a history of a motor vehicle accident.


Subject(s)
Child Abuse/diagnosis , Craniocerebral Trauma/diagnosis , Wounds, Nonpenetrating , Acute Disease , Brain/diagnostic imaging , Brain/pathology , Child , Child, Preschool , Craniocerebral Trauma/complications , Female , Glasgow Coma Scale , Hematoma, Subdural/diagnosis , Hematoma, Subdural/etiology , Humans , Infant , Infant, Newborn , Magnetic Resonance Imaging , Male , Retinal Hemorrhage/diagnosis , Retinal Hemorrhage/etiology , Retrospective Studies , Severity of Illness Index , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL